MediXall Group, Inc.
MDXL
$0.0035
$0.00026.06%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 33.19% | 28.76% | 29.36% | 22.49% | -10.16% |
| Total Depreciation and Amortization | -3.92% | 2,188.89% | 671.43% | 557.89% | 792.50% |
| Total Amortization of Deferred Charges | 62.95% | 298.49% | 3,764.41% | 24,585.71% | -- |
| Total Other Non-Cash Items | -29.19% | 26.30% | -21.72% | -31.23% | 84.04% |
| Change in Net Operating Assets | 69.55% | -37.57% | -19.38% | 124.14% | 191.38% |
| Cash from Operations | 65.47% | 58.91% | 42.75% | 37.64% | 24.00% |
| Capital Expenditure | -- | -75.00% | -75.00% | -75.00% | -75.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 312.50% | 112.50% | 100.00% |
| Cash from Investing | -- | -275.00% | 117.65% | 102.07% | 89.06% |
| Total Debt Issued | -54.63% | -30.46% | 47.05% | 489.51% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.76% | -98.24% | -98.68% | -96.79% | -57.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -64.69% | -57.59% | -47.36% | -18.19% | -14.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 112.31% | 75.95% | -420.21% | 91.61% | 89.68% |
